While Martinez touted tentative agreements for lower class sizes in the youngest grades and more planning time for special ...

Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top drugmaker.

EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections ...

There's a lot of noise in the AI market at the start of 2025. But Microsoft CEO Nadella has seen it all before.

Takeda has named Julie Kim as its next CEO. She will replace Christophe Weber who plans to step down in June of 2026 after leading Japan’s largest drugmaker for 11 years. | Takeda has named Julie Kim ...

Christophe Weber will step down as CEO of Takeda next year, the company announced, following a dropoff in its share price ...

When Takeda CEO Christophe Weber retires from the company in June 2026, a familiar face among the Massachusetts biotech scene will take over leading the Japanese pharma giant.

Acquiring a new company can be a major milestone for small and medium-sized enterprises (SMEs) in terms of rapid growth, diversification, and greater market reach.

Company CEO Mike Peregudov sits down with Streetsblog to talk about his industry and why putting license plates on e-bikes is a non-starter.

Commvault, which Tuesday reported a record third fiscal quarter 2025, is getting ready to support the massive scale of data ...

Hoosiers across the spectrum — from employers to employees, and hospitals to insurers — recognize the burden of high health ...